Concepedia

Virginie Andrzejak

VA

Statistics

Publications

6

Citations

158

H-Index

6

Active since

2010

Affiliations

Université Lille Nord de France(Current)

Inserm

UCLouvain

Université de Lille

Institut de Chimie

Virginie Andrzejak is an author at Université Lille Nord de France specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

2010–2014

6

Publications

6

New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis

Virginie Andrzejak, Giulio G. Muccioli, Mathilde Body–Malapel et al. · Bioorganic & Medicinal Chemistry · 2011 · 41 citations · Full text

, , +12

3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis

Aurélien Tourteau, Virginie Andrzejak, Mathilde Body–Malapel et al. · Bioorganic & Medicinal Chemistry · 2013 · 36 citations · Full text

, , +9

4-Oxo-1,4-dihydropyridines as Selective CB<sub>2</sub>Cannabinoid Receptor Ligands: Structural Insights into the Design of a Novel Inverse Agonist Series

Jamal El Bakali, Giulio G. Muccioli, Nicolas Renault et al. · Journal of Medicinal Chemistry · 2010 · 34 citations · Full text

, , +16

4-Oxo-1,4-dihydropyridines as Selective CB<sub>2</sub> Cannabinoid Receptor Ligands Part 2: Discovery of New Agonists Endowed with Protective Effect Against Experimental Colitis

Jamal El Bakali, Pauline Gilleron, Mathilde Body–Malapel et al. · Journal of Medicinal Chemistry · 2012 · 24 citations · Full text

, , +15

Switching cannabinoid response from CB2 agonists to FAAH inhibitors

Aurélien Tourteau, Natascha Leleu‐Chavain, Mathilde Body–Malapel et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 12 citations · Full text

, , +13

1–5 of 6